Risankizumab 600mg/10ml solution for infusion vials
- SNOMED code
42251911000001105- Active compound
- Risankizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 10 ml, vial
- Ingredients
- Risankizumab
— 60 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Skyrizi 600mg/10ml concentrate for solution for infusion vials (AbbVie Ltd)
in short Skyrizi 600mg/10ml concentrate for inf vials
Skyrizi 600mg/10ml concentrate for solution for infusion vials
- SNOMED code
42248711000001100- Supplier
- AbbVie Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Skyrizi 600mg/10ml concentrate for solution for infusion vials (AbbVie Ltd) 1 vial42248811000001108 ref. pack | 💯 Available Legal category: POM | 08054083023373 | NHS Indicative Price £3,326 | • Hospital |
| — |
Reference packs
Risankizumab 600mg/10ml solution for infusion vials 1 vial
- SNOMED code
42248511000001105- Quantity and unit
- 1 vial
- Packs